Thank you for your participation during the 2018 FLASCO Fall Session. Your involvement and contagious enthusiasm was a key component to another successful program!
Presentations
Friday Evening ~ Caring for Every Patient, Learning from Every Patient
Keynote Speaker ~ Monica M. Bertagnolli, MD, ASCO President
Saturday | General Session ~ Precision Medicine CE
Moderator: Eric Harris, DO, Florida Cancer Specialists and Research Institute
Speaker: Howard McLeod, PharmD, Moffitt Cancer Center/University of South Florida
Difficult Conversations
Beth Sussman | Executive Coach
Panel Questions
Morning Nursing Tracks
Beat the Cancer, Save Your Heart
Natalee Roper, RN,BSN,CHPN | Moffitt Cancer Center
Cathy Elstner RN, BSN | Moffitt Cancer Center
Navigating Patients: Understanding Clinical Trials
Christin Hart, RN, BSN, OCN | Florida Hospital Cancer Institute
Beth Davison, MSN, APRN, CNM | The Leukemia & Lymphoma Society
Afternoon Nursing Tracks
Supportive Care Throughout the Cancer Journey
Ana Rosa Espinosa, DNP, MBA, RN, OCN | Memorial Cancer Institute/Memorial Healthcare System
Palliative Care – Mayra Lima, APRN, MSN, FNP-C | Sylvester Comprehensive Cancer Center/University of Miami
Pain Management – Ana Garcia, APRN, MSN, FNP | Memorial Cancer Institute, Memorial
Healthcare System
Survivorship – Jessica McMillan, DNP, FNP, APRN-BC | Mayo Clinic Florida
Shaping the Future of Healthcare through Nursing
Andrea Uitti, DNP, RN | Florida Cancer for Nursing & Florida Action Coalition
Multi-Disciplinary Morning Tracks
Neoadjuvant Breast Cancer
Surgical –Stephanie A. Valente, DO, FACS | Cleveland Clinic Ohio
Radiation – Amber Orman, MD | Florida Hospital/University of Central Florida
Case Study – Sofia Palacio, MD | Jackson Memorial Hospital/University of Miami Fellowship Program
Multi-Disciplinary Afternoon Tracks
CLL: New and Projected Breakthroughs
Jan A. Burger, MD, PhD | MD Anderson Cancer Center, University of Texas
Case Study – Sonikpreet Aulakh, MD | Mayo Clinic Florida Fellowship Program
Case Study – Jeremy Ramdial, MD | Jackson Memorial Hospital/University of Miami Fellowship Program
Medical – Jingsong Zhang, MD, PhD | Moffitt Cancer Center
Pathology – Jasreman Dhillon, MD | Moffitt Cancer Center
Check back soon for this presentation.
Case Study – Brittany Rogers, MD | University of Florida Fellowship Program
Morning Pharmacy Tracks
Oral Oncolytics
Moderator: Ray Bailey, RPh | Florida Cancer Specialists Rx to Go
Medical Marijuana
Victoria Robinson, PharmD, BCOP | Emory University Hospital Midtown
Marcos Rejtman, DO, HMDC | Memorial Cancer Institute, Memorial Healthcare System
Afternoon Pharmacy Tracks
Revenue Integrity
Moderator: Dina Dumercy McHenry, PharmD, BCOP BCPS | Miami Cancer Institute, Baptist Hospital of Miami
Jorge García, PharmD, MS, MHA, MBA, FACHE | Miami Cancer Institute, Baptist Hospital of Miami
Patient Assistance Best Practices
Sarah Francis, PharmD, BCOP | Jackson Memorial Hospital
Changes in Oncology Clinical Trials Landscape
Anay Moscu, PharmD, BCPS, BCOP | Moffitt Cancer Center
Please check back soon for this presentation.
Poster Presentations
- Candice Baldeo, MBBS, MD ~ Investigating the impact of Physical Activity in Autologous Stem Cell Recipients on QOL Scores during Hospitalization
- Dana Drzayich Antol ~ Advanced care planning and selection of therapy: Influence on hospitalization for patients with metastatic lung cancer
- Shohreh Eliaszadeh, MD ~ Biomarker Testing Survey for Microsatellite Instability/Mismatch Repair
- Reima El Naili, MD ~ Biomarker Testing Survey for NSCC: The role PD-L1 inhibitors testing in clinical practice
- Madiha Iqbal, MBBS, MD ~ Novel dual-affinity BTK/PI3Kγ overcome ibrutinib-resistance in preclinical models of Waldenström Macroglobulinemia
- Jeffrey Trocio ~ Real-world clinical outcomes in patients treated with first-line palbociclib in combination with an endocrine partner at two years post-approval
- Jeffrey Trocio ~ Real-world treatment patterns and clinical outcomes stratified by age, in women with HR+/HER2- advanced/metastatic breast cancer receiving palbociclib combination therapy
- Jennifer Sibley, DNP ~ CheckMate 816: a phase 3 trial of neoadjuvant nivolumab plus ipilimumab or chemotherapy vs chemotherapy in early-stage NSCLC
- Sharad Khurana, MD ~ Inositol Hexaphosphate (IP6) Plus Inositol Induced Complete Remission In Stage IV Melanoma: A Case Report
- Martin Gutierrez, MD ~ Real world incidence, severity and timing of adverse events among patients with metastatic non-small cell lung cancer receiving second-line immuno-oncology therapy vs chemotherapy
- Monica Chatwal, MD ~ Initial tumor flare or mixed tumor response following single PD-1 vs. dual PD-1/CTLA-4 blockade in non-small cell lung cancer (NSCLC)
- Muhamad Alhaj Moustafa, MD ~ Paraneoplastic Frosted Branch Angiitis as First Sign of Relapsed Hodgkin Lymphoma
- Ollie Anum, PharmD ~ Review on kie-C19 Cellular immunotherapy in adults, relapsed or refractory large B-cell lymphoma
- Diana Saravia, MD ~ Clinical Outcomes in Hispanic Patients with Metastatic Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors
- Yen Tran, MBA ~ Medication use evaluation of intravenous acetaminophen among patients in the hematology and oncology unit at Memorial Hospital West in Pembroke Pines, Florida
